Trends in cardiovascular complications of diabetes

JAMA

Volumn 292, Issue 20, 2004, Pages 2495-2499

  Fox, Caroline S ^a,b,c   Coady, Sean ^b   Sorlie, Paul D ^b   Levy, Daniel ^a,b   Meigs, James B ^c   D'Agostino, Ralph B ^d   Wilson, Peter W F ^e   Savage, Peter J ^b  

^a FRAMINGHAM HEART STUDY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Boston University   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

EID: 9244240769     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.20.2495     Document Type: Article

References (44)

1. McGovern PG, Jacobs DR Jr, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota Heart Survey. Circulation. 2001;104:19-24.
2. Guidry UC, Evans JC, Larson MG, et al. Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study. Circulation. 1999; 100:2054-2059.
3. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998:339:861-867.
4. Goldberg RJ, Gorak EJ, Yarzebski J, et al. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation. 1993; 87:1947-1953.
5. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors: the Minnesota Heart Survey Investigators. N Engl J Med. 1996;334: 884-890.
6. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet. 2000;355:688-700.
7. Trends in ischemic heart disease mortality-United States, 1980-1988. MMWR Morb Mortal Wkly Rep. 1992;41:548-549, 556.
8. Trends in ischemic heart disease deaths-United States, 1990-1994. MMWR Morb Mortal Wkly Rep: 1997:46:146-150.
9. Gillum RF, Folsom A, Luepker RV, et al. Sudden death and acute myocardial infarction in a metropolitan area, 1970-1980: the Minnesota Heart Survey. N Engl J Med. 1983;309:1353-1358.
10. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158-2163.
11. Salomaa V, Miettinen H, Kuulasmaa K, et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality: the FINMONICA MI Register Study. Circulation. 1996:94:3130-3137
12. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999:281:1291-1297.
13. Sievers ML, Nelson RG, Bennett PH. Sequential trends in overall and cause-specific mortality in diabetic and nondiabetic Pima Indians. Diabetes Care. 1996:19:107-111.
14. Thomas RJ, Palumbo PJ, Melton U III, et al. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med 2003:163:445-451.
15. Self-reported heart disease and stroke among adults with and without diabetes-United States, 1999-2001. MMWR Morb Mortal Wkly Rep. 2003; 52:1065-1070.
16. Lundberg V, Stegmayr B, Asplund K, Eliasson M, Huhtasaari F. Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J Intern Med. 1997;241:485-492.
17. Lotufo PA, Gaziano JM, Chae CU, et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001; 161:242-247.
18. Liao Y, Cooper RS, Ghali JK, et al. Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease. Diabetes Care. 1993:16:708-713.
19. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001:161:1717-1723.
20. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979:2:120-126.
21. Miettinen H, Lehto S, Salomaa V, et al; FIN-MONICA Myocardial Infarction Register Study Group. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care. 1998:21:69-75.
22. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Heart Study. Ann N Y Acad Sci. 1963;107:539-556.
23. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18-year follow-up. In: Kannel WB, Fordon T, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington, DC: Dept of Health, Education, and Welfare; 1973. DHEW publication (NIH) 74-599, section 30.
24. Cupples LA, D'Agostino RB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Study, 30-year follow-up. In: Kannel WB, Polf PA, Garrison RJ, eds. The Framingham Heart Study: An Epidemiological Investigation of Cardiovascular Disease. Washington, DC: Government Printing Office; 1987. NIH publication 87-203, section 34.
25. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? a practical guide for medical statisticians. Stat Med. 2000;19:1141-1164.
26. SAS/STAT User's Guide, Version 8.2. Cary, NC: SAS Institute Inc; 2001.
27. Lloyd-Jones DM, Martin DO, Larson MG, Levy D. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med. 1998;129:1020-1026.
28. Andresen EM, Lee JA, Pecoraro RE, et al. Under-reporting of diabetes on death certificates, King County, Washington. Am J Public Health. 1993:83:1021-1024.
29. Bild DE, Stevenson JM. Frequency of recording of diabetes on US death certificates: analysis of the 1986 National Mortality Followback Survey. J Clin Epidemiol. 1992:45:275-281.
30. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascularand microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
31. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000:355:253-259.
32. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
33. Curb JD, Pressel SL, Cutler JA, et al; Systolic Hypertension in the Elderly Program Cooperative Research Group. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA. 1996:276:1886-1892.
34. Pyorala K, Pedersen TR, Kjekshus J, et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20:614-620.
35. Goldberg RB, Mellies MJ, Sacks FM, et al; CARE Investigators. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. Circulation. 1998:98:2513-2519.
36. Saaddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136:565-574.
37. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US: 1990-1998. Diabetes Care. 2000; 23:1278-1283.
38. Mokdad AH, Ford ES, Bowman BA, et al. The continuing increase of diabetes in the US. Diabetes Care. 2001;24:412.
39. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
40. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
41. Burke JP, Williams K, Gaskill SP, et al. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med. 1999;159:1450-1456.
42. Stovring H, Andersen M, Beck-Nielsen H, Green A, Vach W. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet. 2003;362:537-538.
43. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180-187.
44. Liu J, Hong Y, D'Agostino RB Sr, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004;291: 2591-2599.